- Moderna Vaccine White Paper: “DNA Vaccines Have a Risk of Permanently Changing a Person’s DNA”
by Dylan Charles, Editor, Waking Times
In light of the conversation and growing debate about the rapid development of a Covid-19 vaccine, many are watching closely to see who wins the race. There is a ton of money in this, as evidenced by the recent $200 billion stock market bubble in vaccines that started when the pandemic began to affect Western nations and politicians and experts began talking up the need for a vaccine in order to ‘return to normal.‘
Stephen Gandel reports for CBS:
“In the past two months alone, Wall Street investors have pumped billions into a handful of biotech companies in the early stages of producing vaccines or drugs to combat the Source]… The result: a coronavirus investment bubble that’s already approaching nearly $200 billion in stock market value.” [
Leading the pack at present is biotech firm Moderna, who recently made headlines for attempting the first human trials of a CV vaccine. Their efforts are financially backed by Bill Gates and when they were first announced, Moderna stock value jumped significantly. However, shortly thereafter a number of participants in the trial reported adverse effects including high fever. Moderna stock has been on a roller coaster ever since.
The New York Post reported on May 18, 2020:
“Biotech company Moderna Inc. dosed 45 patients between the ages of 18 and 55 with 25, 100 or 250 micrograms of its experimental drug. After receiving a second booster shot, those at the 25 and 100 dosage levels were found with antibody levels that were equal to or exceeded those found in patients who recovered from COVID-19, the company said in a press release.” [Source]
On May 22nd, Robert F. Kennedy, Jr. wrote a follow up on the trials, noting:
“Despite Moderna’s cheery press release this week, the clinical trial results for its groundbreaking COVID vaccine could not be much worse.
The vaccine, developed and championed by Anthony Fauci and financed by Bill Gates, used an experimental mRNA technology… Three of the 15 human guinea pigs in the high dose cohort (250 mcg) suffered a ‘serious adverse event’ within 43 days of receiving Moderna’s jab. Moderna…acknowledged that three volunteers developed Grade 3 systemic events defined by the FDA as ‘Preventing daily activity and requiring medical intervention’.
Moderna allowed only exceptionally healthy volunteers to participate in the study. A vaccine with those reaction rates could cause grave injuries in 1.5 billion humans if administered to ‘every person on earth’.” ~Robert F Kennedy, Jr.
Out of concern for health freedom and public awareness we looked a little deeper into this issue, and while there is relatively little reporting on this to date, a 2017 Moderna white paper entitled, mRNA Vaccines: Disruptive Innovation in Vaccination, touches on this issue. In a section titled ‘DNA Vaccines,’ the following safety concern about DNA vaccines (not mRNA vaccines ) is documented:
“DNA vaccine work began thirty years ago, but as yet there are no licensed DNA vaccines and most remain in Phase 1 testing.
The key challenge associated with DNA vaccines is that they must penetrate the cell nucleus (crossing two membranes; the cytoplasm and the nucleus). The DNA must then be transcribed in the nucleus into mRNA before moving to the cytoplasm to stimulate antigen production. This core complex pathway often requires both larger doses and special, often painful delivery devices using electric shocks or gold microspheres into person’s skin to deliver the DNA vaccine. Once inside the nucleus, DNA vaccines have a risk of permanently changing a person’s DNA.” [Source]